Médicaments antirhumatismaux modificateurs de la maladie
DMARDS
Revu par Dr Hayley Willacy, FRCGP Dernière mise à jour par Dr Colin Tidy, MRCGPDernière mise à jour 19 nov 2022
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Version audio
- Ajouter aux sources préférées sur Google
Dans cette série :Polyarthrite rhumatoïdeMédicaments biologiques pour la polyarthrite rhumatoïdeArthrite juvénile idiopathique
Disease-modifying antirheumatic drugs (DMARDs) are medicines that are normally prescribed as soon as rheumatoid arthritis (RA) is diagnosed, in order to reduce damage to the joints. Rarely, they can have serious side-effects affecting the blood, liver, or kidneys. DMARDS are usually taken for the rest of your life. Because they are taken for a long time you need to have regular blood tests, to see if the DMARDs are having any side-effects.
En un coup d'œil
DMARDs are medicines for rheumatoid arthritis that ease symptoms and reduce joint damage.
They work by blocking chemicals involved in joint inflammation.
DMARDs are prescribed early after diagnosis to prevent joint damage and slow disease progression.
It can take several weeks or months for DMARDs to start working.
Regular blood tests are needed to monitor for serious side-effects.
You should not take DMARDs if you are pregnant, breastfeeding, or have severe organ problems or infections.
Report any suspected side-effects through the Yellow Card Scheme.

Vous n'êtes pas sûr de mélanger des médicaments ?
Vérifiez les interactions possibles entre les médicaments, les compléments et les aliments avant de les prendre ensemble.
What are DMARDs: disease-modifying antirheumatic drugs?
Disease-modifying antirheumatic drugs (DMARDs) are a group of medicines that are used to ease the symptoms of polyarthrite rhumatoïde (PR) and reduce the damaging effect of the disease on the joints.
There are quite a few DMARDs available to treat RA. They include:
They come in various different brand names.
There is a group of newer medicines called biological therapies which can also be used to treat RA. Like DMARDs they have a disease-modifying effect against RA and are sometimes called cytokine modulators or monoclonal antibodies. Biological therapies include adalimumab, certolizumab pegol, etanercept, golimumab, infliximab, anakinra, abatacept, rituximab and tocilizumab. Biological therapies are not discussed further in this leaflet. See the separate leaflet called Biological medicines for rheumatoid arthritis.
DMARDs are also used to treat other conditions - for example, chronic inflammatory skin or bowel disease. However, the rest of this leaflet is only about DMARDs when they are used to treat RA.
What is rheumatoid arthritis?
Arthritis means inflammation of joints. Rheumatoid arthritis (RA) is a common form of arthritis. The main symptoms are pain and stiffness of affected joints.
RA is thought to be an autoimmune disease. The immune system normally makes small proteins (antibodies) to attack bacteria, viruses, and other germs.
In people with autoimmune diseases, the immune system makes antibodies against tissues of the body. It is not clear why this happens.
In people with RA, antibodies are formed against the tissue that surrounds joints (the synovium). This causes inflammation in and around affected joints.
Over time this can damage the joint, the cartilage, and parts of the bone near the joint.
The most commonly affected joints are the small joints of the fingers, thumbs, wrists, feet and ankles.
For more information see the separate leaflet called Rheumatoid arthritis.
How do DMARDs work?
We are still not sure exactly how DMARDs work. But it is thought that they work by blocking the way inflammation develops in the joints, by blocking certain chemicals involved in the inflammation process.
When are DMARDs usually prescribed?
DMARDs are prescribed as soon as possible after RA has been diagnosed, by doctors who specialise in treating RA. Most people with RA have flare-ups followed by better spells. During these flare-ups some damage may be done to the joints. If DMARDs are taken in the early stages of RA they can prevent joint damage and help to slow down the progression of the disease.
Which DMARDs are usually prescribed?
One of methotrexate, leflunomide, or sulfasalazine is the DMARD often chosen for initial treatment. However, the choice of medicine will depend on many issues about you and your illness. Your specialist will discuss the choices, so you have the medicine best suited for you.
When choosing a DMARD your doctor will talk to you about the differences between them and look for any reasons why you may not be able to take one over another. Some people are only prescribed one DMARD; others try several before one or more can be found to suit. Your doctor will advise if it is better for you to take one or two DMARDs.
How quickly do DMARDs work?
It can take several weeks or months for DMARDs to ease the pain and inflammation caused by RA. Therefore, in addition, other medicines are normally advised for a time to help control symptoms until DMARDs start working. These may be steroid medicines, anti-inflammatory medicines and/or other painkillers.
Corticostéroïdes, des médicaments anti-inflammatoires et antalgiques ease the pain and reduce inflammation of RA. Anti-inflammatory medicines and painkillers do not provide the benefits that DMARDS give of preventing joint damage and slowing down the disease progression. Steroids can prevent joint damage if they are given in low doses and taken over a long period of time. However, they are not usually prescribed this way anymore. If a DMARD does not work after six months then your doctor will normally change your treatment.
Methotrexate, sulfasalazine, intramuscular gold and penicillamine are all thought to work as well as each other. However, in general, methotrexate and sulfasalazine are better tolerated and have less serious side-effects.
DMARDs side-effects
It is not possible to list all the adverse effects of each DMARD in this leaflet. However, as with all medicines, there are a number of side-effects that have been reported with each of the DMARDs, some of which are serious. Serious side-effects are rare, but include damage to the liver and blood-producing cells. For more detail see the information leaflet that came with your medicine.
You must talk to your doctor or pharmacist if you develop:
A sore throat, unexplained bruising, or mouth ulcers (signs of a problem with your blood).
Also, you must talk to your doctor or pharmacist if you develop any of the following:
A feeling of sickness (nausea).
Être malade (vomissements).
Tummy (abdominal) discomfort.
Yellowing of your skin or the whites of your eyes (jaundice).
Dark urine (signs of a problem with your liver).
Also, DMARDs sometimes react with other medicines that you may take. So, make sure your doctor knows of any other medicines that you are taking, including ones that you have bought rather than been prescribed.
Consultez la notice qui accompagne votre marque spécifique pour une liste complète des effets secondaires possibles et des précautions.
How often should I have blood tests when taking a disease-modifying antirheumatic drug?
Because these medicines are usually taken for a long time and they can have serious side-effects, it is usual to have regular tests - usually blood tests - whilst you take them. The tests look for some possible side-effects before they become serious.
Before DMARDs are started
Blood tests are always taken before you start treatment with a DMARD. This is to see if your liver, kidneys and blood are normal. If there are any problems, your doctor will talk to you about this. Blood tests help your doctor decide which DMARD is best for you or if another type of treatment is better for you.
After DMARDs are started
In the first six months of treatment blood tests are taken often. How often you have a blood test depends upon which DMARD you are taking. Your doctor will advise. For example, at first it can be every two to four weeks. After six months, if you have no problems, blood tests may then be taken every three months.
What will happen if my blood tests are not normal?
If there is a problem with your blood test you will usually be asked to stop taking the DMARD. Your GP will need to discuss the results of your blood test with the specialist to see what treatment you may need. In most people, once the medicine is stopped the blood, liver or kidneys return to normal.
Length of treatment
If DMARDs work well, it is usual to take one or more DMARDs for the rest of your life. When your RA is well controlled, your doctor may advise you to lower the dose (very slowly). This is in order for you to take the lowest dose and to keep the disease under control.
Can I buy DMARDs?
No. They are only available from your pharmacist, with a doctor's prescription.
Who cannot take DMARDs?
It is not possible in this leaflet to list every type of condition or type of person who cannot take each DMARD. However, in general, doctors do not prescribe DMARDs if you:
Are pregnant or breastfeeding.
Have severe liver or kidney problems.
Have a severe blood disorder.
Have a serious infection.
Have an immunodeficiency syndrome.

Vous n'êtes pas sûr de mélanger des médicaments ?
Vérifiez les interactions possibles entre les médicaments, les compléments et les aliments avant de les prendre ensemble.
Sélections des patients pour Médicaments pour les os et les muscles

Traitement et médicaments
Bisphosphonates
Les bisphosphonates sont un groupe de médicaments utilisés pour traiter les affections qui touchent vos os. Différents bisphosphonates sont disponibles pour différentes affections.
par Dr Colin Tidy, MRCGP

Traitement et médicaments
Médicaments biologiques pour la polyarthrite rhumatoïde
Les médicaments biologiques sont un type plus récent de médicaments, utilisés pour soulager les symptômes de la polyarthrite rhumatoïde et réduire l'effet néfaste de la maladie sur les articulations. Ils sont généralement prescrits lorsque vous avez essayé des médicaments plus anciens appelés médicaments antirhumatismaux modificateurs de la maladie (DMARDs) et que ceux-ci n'ont pas bien fonctionné. Si un médicament biologique doit fonctionner, vous vous sentirez généralement mieux dans les 12 semaines suivant le début du traitement. Les médicaments biologiques vous rendent plus sujet aux infections et endommagent parfois les cellules productrices de sang. Vous devriez toujours avoir sur vous une carte d'alerte de thérapie biologique. Cela permet de s'assurer que tout médecin ou infirmier qui vous traite sache que vous prenez un médicament biologique et que vous êtes à risque accru de développer une infection grave.
par Dr Doug McKechnie, MRCGP
Questions fréquemment posées
What is the primary difference between DMARDs and biological therapies?
DMARDs and biological therapies both modify the disease and are used to treat rheumatoid arthritis. Biological therapies are a newer group of medicines, sometimes referred to as cytokine modulators or monoclonal antibodies, but they essentially serve a similar disease-modifying role to DMARDs.
Other than rheumatoid arthritis, what other conditions can DMARDs treat?
DMARDs are also effective in treating other conditions, such as chronic inflammatory skin diseases or inflammatory bowel diseases.
If my blood tests are abnormal, what is the usual outcome?
If an issue is detected with your blood test, you will typically be advised to stop taking the DMARD. Your GP will then discuss the results with a specialist to determine the next steps for your treatment. In most cases, once the medicine is stopped, the blood, liver, or kidneys return to their normal state.
Can I stop taking DMARDs if my rheumatoid arthritis is under control?
If DMARDs are working effectively and your rheumatoid arthritis is well controlled, it is common to continue taking one or more DMARDs for the rest of your life. Your doctor might gradually reduce the dose to find the lowest effective amount needed to keep the disease under control.
How do I report a side-effect from my DMARD?
You can report any suspected side-effects from your medication through the Yellow Card Scheme, which can be accessed online at www.mhra.gov.uk/yellowcard. When reporting, it's helpful to have information about the side-effect, the name of the medicine, details of the person who experienced it, and your contact information.
Lectures complémentaires et références
- Formulaire National Britannique (BNF); Services de Preuves NICE (accès réservé au Royaume-Uni)
- Ledingham J, Gullick N, Irving K, et al; BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs. Rheumatology (Oxford). 2017 Jun 1;56(6):865-868. doi: 10.1093/rheumatology/kew479.
- Polyarthrite rhumatoïde chez l'adulte : prise en charge; Ligne directrice NICE (juillet 2018 - dernière mise à jour octobre 2020)
- DMARDs; NICE CKS, décembre 2023 (accès réservé au Royaume-Uni)
À propos de l'auteur

Jenny Whitehall
BSc (Hons), Diploma in Pharmacy Practice
À propos du critiqueVoir la biographie complète

Dr Hayley Willacy, FRCGP
Médecin généraliste, Auteur médical
MBChB (1992), DRCOG, DFFP, MRCOG (Part 1) MRCGP (2007), DFSRH (2013), MSc - medical education (2020)
Le Dr Hayley Willacy était médecin généraliste au NHS travaillant dans le nord-ouest de l'Angleterre, qui a pris sa retraite de la pratique clinique en 2022 après 30 ans.
Historique de l'article
Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
Article également disponible en Anglais, Allemand, Espagnol, Français, Italien, Portugais, Hindi, Hébreu, Arabe, and Suédois.
Prochaine révision prévue : 7 oct. 2027
19 nov 2022 | Dernière version
15 Dec 2011 | Publié à l'origine
Écrit par :
Jenny Whitehall

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.

Vous ne vous sentez pas bien ?
Évaluez vos symptômes en ligne gratuitement
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.
Plus sur le traitement et les médicaments
- Traitements de l'acné
- Anaphylaxie
- Gestion de la colère
- Antiacides
- Antihistaminiques
- Antispasmodiques
- Médicaments antithyroïdiens
- Bêta-bloquants
- Bloqueurs des canaux calciques
- Chimiothérapie
- Gérer un adulte qui ne répond pas
- Bêta-lactamases à spectre étendu
- Thérapie par le chaud et le froid pour soulager la douleur
- Inhalateurs pour MPOC
- Diurétiques de l'anse
- Médicaments et traitements pour la démence
- Vaccination ROR
- Pédicurie
- Corticostéroïdes
- Vaccin contre la fièvre jaune